09/30/2014 - 12:55pm

Salix Pharmaceuticals and Progenics Pharmaceuticals announced that the Food and Drug Administration approved Relistor (methylnaltrexone bromide) subcutaneous injection in 12-mg dosage strength to treat constipation in patients taking opioids for chronic, non-cancer pain. 

09/30/2014 - 12:42pm

Camber Pharmaceuticals, a generic drugs supplier, presented Target with its "Outstanding Partnership" award for 2014. 

09/30/2014 - 11:42am

Wholesaler H.D. Smith last week promoted Dmitrey Kuznetsov to VP generic pharmaceuticals. 

09/30/2014 - 11:13am

Johnson & Johnson on Tuesday announced a definitive agreement to acquire Alios BioPharma, a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.8 billion in cash.

09/29/2014 - 4:56pm

Health experts argue that there are tactics that payers and purchasers can deploy to help improve patient access.

09/29/2014 - 11:20am

According to a report released Monday by Thomson Reuters BioWorld, currently there are 700 follow-on biologics therapies moving through pipelines with many already approved.

09/29/2014 - 11:00am

Diplomat Pharmacy on Monday announced that it has commenced its initial public offering of 13.3 million shares of its common stock.

 

09/29/2014 - 10:48am

CARE Pharmacies last week announced that they have selected PDX’s Enterprise Pharmacy System as the regional drug chain’s pharmacy system of choice. 

09/29/2014 - 9:06am

Cardinal Health Specialty Solutions and KEW Group agree to make KEW's diagnostic services available to Specialty Solutions' community oncology customers.